Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants

Vaccine

Volumn 19, Issue 11-12, 2001, Pages 1503-1510

  Schnorr, Jens Jörg ^a,d   Cutts, Felicity T ^b   Wheeler, Jeremy G ^b   Akramuzzaman, S M ^c   Alam, M Samiul ^c   Azim, Tasnim ^c   Schneider Schaulies, Sibylle ^a   Ter Meulen, Volker ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ICDDRB Laboratory Sciences Division   (Bangladesh)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cytokines; Lymphocyte activation; Measles vaccination

Indexed keywords

CANDIDA ANTIGEN; INTERLEUKIN 2; MEASLES VACCINE;

ARTICLE; BANGLADESH; CHILDHOOD MORTALITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT OUTCOME;

ANTIBODIES, VIRAL; BANGLADESH; CYTOKINES; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNIZATION SCHEDULE; INFANT; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MEASLES VACCINE; MEASLES VIRUS;

EID: 0035825082     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00349-2     Document Type: Article

References (23)

1. The optimal age for administering measles vaccine in developing countries
2. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants
3. Increased mortality after high titer measles vaccines: Too much of a good thing
4. Pathogenesis of measles virus infection: An hyopthesis
5. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age
6. Non-specific beneficial effect of measles immunization: Analysis of mortality studies from developing countries
7. Increased morbidity after measles is short-term in urban Bangladesh
8. Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre edmonston-zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire
9. The first international standard for anti-measles serum
10. Measles antibody: Reevaluation of protective titres
11. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression
12. Delayed cutaneous hypersensitivity: Epidemiologic factors affecting and usefulness in predicting diarrhoeal incidence in young peruvian children
13. Maternal measles antibody decay in rural Bangladeshi infants-implications for vaccination schedules
14. Measles among under-9-month-olds in rural Bangladesh: Its significance for age at immunization
15. Measles control in kinshasa, zaire improved with high coverage and use of medium titre edmonston zagreb vaccine at age 6 months
16. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in guinea-bissau: Five years follow-up
17. Kinetics of immunologic responses after primary MMR vaccination
18. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune responses in infants
19. Infection of leucocytes by measles vaccine viruses Edmonston-Zagreb and Enders-Moraten has different consequences: Potential mechanism for increased vaccine efficacy or aberrant activity in field trials
20. Changes in cytokine production after measles virus vaccination: Predominant production of IL-4 suggests induction of a Th2 response
21. Cytokines acting on or secreted by macrophages during intracellular infection (IL10, IL-12, IFN-γ)
22. Changes in intracellular cytokine levels in lymphocytes induced by measles virus
23. Activation of HIV expression by CD30 triggering in CD4+T cells from HIV-infected individuals